MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover the role of genetic testing in diagnosing Cleidocranial Dysplasia 1, Forme Fruste, with Brachydactyly, and how it helps manage symptoms and improve quality of life.
Discover the benefits of genetic testing for diagnosing Cleidocranial Dysplasia 1, Forme Fruste, Dental Anomalies, and its impact on personalized treatment plans.
Discover the role of genetic testing in diagnosing Cleidocranial Dysplasia 2 (CCD2), a rare bone disorder, and how it helps patients make informed decisions.
Discover the importance of genetic testing for CYP2C19 variants in determining clopidogrel response, enabling personalized treatment plans and improved patient outcomes.
Discover the role of genetic testing in diagnosing & treating cocaine-related disorders, identify genetic risk factors, and personalize treatment for better outcomes.
Discover the importance of genetic testing in diagnosing Cone-Rod Dystrophy 24, understanding inheritance patterns, exploring treatment options, and participating in research…
Discover the importance of genetic testing for diagnosing and managing Congenital Heart Defects, Multiple Types, 9 (CHD9) and its role in guiding treatment plans.
Discover the role of genetic testing in diagnosing congenital muscular alpha-dystroglycanopathy with brain & eye anomalies (MEB disease) and its potential future applications.